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2003 to 2013 with a query of PubMed and EBSCOHost
databases. Eleven articles ﬁtting speciﬁed criteria were
published assessing outcomes associated with elective
B/FEVAR for TAAA (n ¼ 1006 patients). Data for 30-
day and long-term mortality, technical success, complica-
tions, and morbidity were gathered. SCI and protective
strategies, as well as Crawford classiﬁcation of extent of
coverage, were also collected and pooled for categorical
analysis.
Results: Crawford classiﬁcation included type I (n ¼
44), type II (n ¼ 110), type III (n ¼ 228), and type IV
(n ¼ 624) aneurysms. The 30-day mortality was 5.4%
(n ¼ 54). The 1- and 2-year reported survival were 74.9%
and 57.4%, respectively. SCI occurred in 7.1% (observed/
expected, 1.41), and acute renal failure was reported in
13.4% of patients. Technical success was 96.8%, with
endoleaks occurring in 18.8%, and reintervention during
follow-up required in 19.0%. Branch patency rates ranged
from 76.9% in early experiences to 98.0% in late
experiences.
Conclusions: When compared with open centers of
excellence, B/FEVAR for TAAA has similar periopera-
tive mortality rates but worse SCI rates. This data sug-
gests the branched graft TAAA repair carries a greater
risk of paraplegia or less effective spinal cord protective
measures are used because of the misperception of less
risk.
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Objectives: Starting in December 2013, the Hospital
Inpatient Quality Reporting Program includes Clos-
tridium difﬁcile (C diff) infection rates as a new publi-
cally reported quality measure. Our goal was to review
the incidence, trend, and hospital variability in C diff
rates as well as associated risk factors and costs in vascular
surgery.
Methods: The incidence of C diff diagnoses after ma-
jor vascular procedures of abdominal aortic aneurysm
(AAA) repair, carotid and lower extremities revasculariza-
tion (LER), and LE amputation was identiﬁed using
Nationwide Inpatient Sample database for 2000 to 2010.
Costs were assessed using cost-to-charge ratio. Risk factors
associated with C diff were analyzed with hierarchical
multivariate logistic regression.
Results: During the past decade, the rates of C diff
after vascular procedures had steadily increased by 66%,
from 0.6 to 0.99%. In 2010, the highest rates were after
ruptured AAA repair (2.7%), whereas the lowest rates
were after carotid endarterectomy (0.1%). The incidenceof C diff increased after open AAA, endo-LER, and
carotid endarterectomy by 141%, 115%, and 40%, respec-
tively. In 2010, patients who had experienced C diff had
median length of stay of 15 days (interquartile range, 9,
26 days), in-hospital mortality of 9.8%, and $20,600 ex-
tra cost per hospitalization. The national cost associated
with C diff treatment wasw$86.7 million. Hospital inci-
dence of C diff varied from 0% to 50%, with 3.5% of hos-
pitals having infection rates $5%. Factors associated with
C diff included patient advanced age, female gender,
renal insufﬁciency, multiple chronic conditions, emer-
gency and weekend hospitalizations, hospital transfers,
surgery type, and hospital characteristics (large, urban,
public, and smaller Registered Nurse full-time equiva-
lents rates).
Conclusions: Despite potential reduction of infection
rates, as evidenced by the experience of hospitals with
effective interventions, C diff incidence is increasing among
vascular patients and is associated with prolonged length of
stay, increased mortality, and higher costs.
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Objectives: Perioperative acute kidney injury (AKI)
is common, but has only been studied in select vascular
surgery subgroups. We studied the incidence, risk fac-
tors, and outcomes of AKI in a broad vascular surgery
cohort.
Methods: This was a retrospective analysis of vascular
patients from a 1-year cohort of surgical ICU admissions
at a tertiary hospital. Patients were identiﬁed from a pro-
spective APACHE (Acute Physiology and Chronic Health
Evaluation) IV database. The end point was AKI by RI-
FLE creatinine (Cr, mg/dL) criteria (increase vs baseline:
Risk, $1.5; Injury, $2; Failure, $3). Outcomes
were inpatient and 1-year mortality, surgical intensive
care unit (SICU) and hospital lengths of stay and
discharge Cr. AKI and non-AKI groups were compared
by univariate analysis, and AKI risk factors were assessed
by multivariate regression.
Results: Of 628 SICU admissions, 136 (22%) were
vascular patients (28% of all vascular patients). AKI devel-
oped in 65 (48%), a rate similar to nonvascular patients
(234 of 492 [48%]; P ¼ 1.0). AKI and non-AKI patients
had similar baseline Cr (0.90 6 0.44 vs 0.96 6 0.46 mg/
dL; P ¼ .73). Independent risk factors for AKI were
increasing illness severity (APACHE III >50: odds ratio,
